Exact Sciences Licenses Invader Technology from Hologic | GenomeWeb

NEW YORK (GenomeWeb News) – Exact Sciences said Tuesday that it has licensed worldwide rights to Hologic's Invader plus and real-time Invader detection chemistries for colorectal screening applications.

Terms of the agreement are not being disclosed by the firms.

The Invader chemistry was developed by Hologic subsidiary Third Wave Technologies, which formerly was run by Exact Sciences' current President and CEO Kevin Conroy, before it was acquired by Hologic for $580 million in July 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.